Sitagliptin for the Prevention and Treatment of Hyperglycemia in Patients With Type 2 Diabetes Undergoing Cardiac Surgery

Trial Profile

Sitagliptin for the Prevention and Treatment of Hyperglycemia in Patients With Type 2 Diabetes Undergoing Cardiac Surgery

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Aug 2017

At a glance

  • Drugs Sitagliptin (Primary) ; Insulin; Insulin aspart; Insulin glargine; Insulin lispro
  • Indications Hyperglycaemia; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms SITA-CABGDM
  • Most Recent Events

    • 25 Jan 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
    • 24 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top